Circulating Hybrid Cells: A Novel Liquid Biomarker of Treatment Response in Gastrointestinal Cancers

Authors:

Abstract
Real-time monitoring of treatment response with a liquid biomarker has potential to inform treatment decisions for patients with rectal adenocarcinoma (RAC
Funding Information
  • U.S. Department of War (W81XWH-18-1-0621)
  • Oregon Health and Science University (Medical Research Foundation Early Clinical Investi)
  • National Cancer Institute (P30 CA069533)
  • Newton Esophageal Cancer Foundation (Esophageal Research Grant)
  • Collins Medical Trust (Research Grant)

This publication has 46 references indexed in Scilit: